Schiller Asia Pacific Sdn Bhd
⚠️ Moderate Risk
FEI: 3010418303 • Kuala Lumpur, Wilayah Persekutuan • MALAYSIA
FEI Number
3010418303
Location
Kuala Lumpur, Wilayah Persekutuan
Country
MALAYSIAAddress
Jalan Ara 10, , Kuala Lumpur, Wilayah Persekutuan, Malaysia
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
Refusal History
Frequently Asked Questions
What is Schiller Asia Pacific Sdn Bhd's FDA import refusal history?
Schiller Asia Pacific Sdn Bhd (FEI: 3010418303) has 1 FDA import refusal record(s) in our database, spanning from 2/11/2014 to 2/11/2014.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Schiller Asia Pacific Sdn Bhd's FEI number is 3010418303.
What types of violations has Schiller Asia Pacific Sdn Bhd received?
Schiller Asia Pacific Sdn Bhd has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Schiller Asia Pacific Sdn Bhd come from?
All FDA import refusal data for Schiller Asia Pacific Sdn Bhd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.